Objective
To estimate the prevalence and risk factors for a diagnosis of cranial cruciate ligament (CCL) disease in dogs and to describe the management of such cases attending primary‐care veterinary practices.
Study design
Historical cohort with a nested case–control study.
Sample population
Nine hundred and fifty‐three dogs diagnosed with CCL disease from 171,522 dogs attending 97 primary‐care practices in England.
Methods
Medical records of dogs attending practices participating in the VetCompass project that met selection criteria were assessed. Univariate and multivariate logistic regression methods were used to evaluate association of possible risk factors with diagnosis of CCL disease.
Results
The prevalence of CCL disease diagnosis was estimated at 0.56% (95% confidence interval 0.52–0.59). Compared with crossbred dogs, Rottweilers, West Highland White Terriers, Golden Retrievers, Yorkshire Terriers, and Staffordshire Bull Terriers showed increased odds of CCL disease diagnosis while Cocker Spaniels showed reduced odds. Increasing bodyweight within breeds was associated with increased odds of diagnosis. Dogs aged over 3 years had increased odds of diagnosis compared with dogs aged less than 3 years. Neutered females had 2.1 times the odds of diagnosis compared with entire females. Insured dogs had 4 times the odds of diagnosis compared with uninsured dogs. Two‐thirds of cases were managed surgically, with insured and heavier dogs more frequently undergoing surgery. Overall, 21% of cases were referred, with referral more frequent in heavier and insured dogs. Referred dogs more frequently had surgery and an osteotomy procedure.
Conclusion
Breed predispositions and demographic factors associated with diagnosis and case management of CCL disease in dogs identified in this study can be used to help direct future research and management strategies.
This is the peer-reviewed, manuscript version of an article published in Veterinary Record. The final version is available online via http://dx.doi.org/10.1136/vr.104528.The full details of the published version of the article are as follows: TITLE: Comparison of medical and surgical treatment for acute cervical compressive hydrated nucleus pulposus extrusion in dogs AUTHORS: Borlace, T., Gutierrez-Quintana, R., Taylor clinical presentation, or imaging findings between both groups. Two dogs in the medically 30 managed group underwent surgical decompression due to an unsatisfactory response to 31 medical management. All cases for which long-term information was available (n=30) were 32 neurologically normal at the time of data collection. There were no significant differences for 33 any of the short or long-term outcome variables between both treatment groups. This study 34 demonstrated successful outcomes after medical or surgical treatment and suggests that both 35 treatment modalities can be considered for dogs with cervical HNPE. 36 37
17Objectives: The aim of the study was to describe the clinical features, diagnostic imaging 18 findings, treatment and outcome in cats diagnosed with presumptive acute non-compressive 19 nucleus pulposus extrusion. Results: Eleven cats met the inclusion criteria. All cats had a peracute onset of clinical signs,
25with eight cats experiencing witnessed (n = 6) or suspected (n = 2) external trauma.
The thymus is crucial for T-cell output and the age-associated involution of this organ, is thought to have a major impact in the decline in immunity that is seen in later life. The mechanism that underlines thymic involution is not known, however, we have evidence to suggest that this is may be due to changes in the thymic microenvironment. To further test this hypothesis, we quantified the in situ changes to markers that identify cortical and medullary thymic epithelial cells. This analysis revealed an age-dependent decline in cortical and medullary markers together with an increase in Notch and Delta expression, in older mice, as judged by immunohistochemistry. This was accompanied by alterations of the archetypal staining patterns and three dimensional analysis revealed changes in the morphology of the thymic microenvironment. These studies suggest that there are age-associated alterations in the thymic microenvironment, which may therefore play a role in thymic involution.
A 9-month-old domestic shorthair cat had progressive ambulatory paraparesis, proprioceptive ataxia, and thoracolumbar hyperesthesia. An extradural mass affecting the left pedicle and lamina of the second lumbar vertebra (L2) causing marked spinal cord impingement was identified in magnetic resonance (MR) images. The mass was predominantly calcified in computed tomographic (CT) images. A hemilaminectomy was performed to resect the mass. Clinical signs were greatly improved at 12-month follow-up. The histopathologic diagnosis was vascular hamartoma. To our knowledge, this is the first report describing the MR characteristics of a vascular hamartoma associated with the vertebral column.
An 8-year-old male intact miniature poodle presented for blindness, obtundation, tetraparesis and vestibular signs. Magnetic resonance imaging (MRI), radiography and ultrasound revealed a left piriform lobe lesion, right cerebellar and left brainstem lesions, hydrocephalus and bilateral calvarial defects. Histopathology confirmed a choroid plexus carcinoma with meningeal and intraventricular metastases. The calvarial defect did not show evidence of necrosis, osteoclastic resorption, inflammation or neoplastic infiltration, reflecting a quiescent calvarial atrophy or dysplasia. The imaging characteristics are indicative of calvarial atrophy secondary to chronic increased intracranial pressure and this is the first report of a calvarial defect of this size.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.